Loading clinical trials...
Loading clinical trials...
Idiopathic Pulmonary Fibrosis (IPF) is a fibrosing progressive interstitial lung disease with unknown etiology, with a median survival of 3 years since first diagnosis. The typical radiologic pattern ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Modena and Reggio Emilia
NCT06527612 · Fibrosis, Pulmonary, Pulmonary Rehabilitation
NCT05604495 · Cystic Fibrosis, Pulmonary
Azienda Ospedaliero Universitaria Policlinico di Modena
Modena
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions